For example, the results of a meta-analysis substantiated the high specificity of promoter methylation of GSTP1 in cell-free DNA (cfDNA) for the diagnosis of prostate cancer, and this could be used to more precisely evaluate the prognosis of patients with this type of cancer [221]. This evidence concerns the gene GSTP1 and prostate cancer.